The Utilization Spectrum of Cardiac Output Monitoring Devices among Anesthesiology Programs Across Veterans Health Administration in the United States

被引:0
|
作者
Porhomayon, Jahan [1 ]
Pourafkari, Leili [1 ]
Mahmoodpoor, Ata [2 ]
Nader, Nader D. [1 ]
机构
[1] SUNY Buffalo, Dept Anesthesiol, Buffalo, NY USA
[2] Tabriz Univ Med Sci, Dept Anesthesiol, Tabriz, Iran
关键词
Anesthesiologist; cardiac output; hemodynamic; physiologic; RANDOMIZED CLINICAL-TRIAL; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; FLUID RESPONSIVENESS; DOPPLER; KNOWLEDGE; THERAPY;
D O I
10.4103/aca.ACA_107_18
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Electronic monitoring of physiologic variables has gained widespread support over the past decade for critical patients in the intensive care setting. Specifically, anesthesiologists have increased the emphasis and practice of hemodynamic control through monitoring cardiac output (CO). However, these physicians are presented with several options in terms of how they wish to study the trend of this physiologic parameter. Materials and Methods: A survey was distributed to 250 general and subspecialty-trained anesthesiologists. A series of questions were presented in terms of preference of patient monitoring methods requiring yes or no answers. Anesthesiologists were asked about subspecialty training, years since residency graduation, and preferences toward specific hemodynamic monitoring tools. Nonparametric statistical analysis and Chi-squared tests were used to analyze both normal and nonnormally distributed data. Results: CO monitoring devices were implemented by 106 out of 133 anesthesiologists, with 98 of these physicians utilizing CO monitoring for fluid and vasopressors response. Of the physicians implementing a monitoring device, 48 out of 107 physicians preferred pulmonary artery catheter, while pulse contour analysis was preferred by 17 anesthesiologists. An echocardiography unit was available to the department for 90 anesthesiologists, and 77 anesthesiologists were trained to use this technology for monitoring cardiac function. Conclusion: Many anesthesiologists have placed emphasis on the importance of CO monitoring within the intensive care setting. However, physicians are still faced with multiple options in terms of how they wish to specifically monitor this hemodynamic variable. Factors that influence such decisions include the time of physician's residency training along with patient and clinical case characteristics.
引用
收藏
页码:199 / 203
页数:5
相关论文
共 32 条
  • [1] Mental health and addiction service use among United States veterans with liver disease nationally in the Veterans Health Administration
    Haque, Lamia
    Rosenheck, Robert
    JOURNAL OF PUBLIC MENTAL HEALTH, 2021, 20 (03) : 191 - 200
  • [2] Telemedicine utilization trends among patients with multiple sclerosis and controls in the united states veterans health administration: 2008-2020
    Magid, H. Abdel
    Jin, S.
    Culpepper, W.
    Nelson, L.
    Wallin, M.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 355 - 355
  • [3] Impact of treatment duration on mortality among Veterans with opioid use disorder in the United States Veterans Health Administration
    Ching, Jack H.
    Owens, Douglas K.
    Trafton, Jodie A.
    Goldhaber-Fiebert, Jeremy D.
    Salomon, Joshua A.
    ADDICTION, 2021, 116 (12) : 3494 - 3503
  • [4] Barriers to Utilization of Prescription Drug Monitoring Programs Among Prescribing Physicians and Advanced Practice Registered Nurses at Veterans Health Administration Facilities in Oregon
    Mastarone, Ginnifer L.
    Wyse, Jessica J.
    Wilbur, Eileen R.
    Morasco, Benjamin J.
    Saha, Somnath
    Carlson, Kathleen F.
    PAIN MEDICINE, 2020, 21 (04) : 695 - 703
  • [5] Clozapine utilization at the United States Veterans Health Administration: a descriptive report of prescribing patterns and patient characteristics among Operation Enduring Freedom/Operation Iraqi Freedom Veterans
    Zuschlag, Zachary D.
    Fowler, Christopher A.
    Devendorf, Andrew
    Panaite, Vanessa
    Efimova, Olga
    Schultz, Susan K.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2020, 35 (06) : 322 - 328
  • [6] Patient characteristics and treatment utilization in fatal stimulant-involved overdoses in the United States Veterans Health Administration
    Coughlin, Lara N.
    Zhang, Lan
    Bohnert, Amy S. B.
    Maust, Donovan T.
    Goldstick, Jason
    Lin, Lewei
    ADDICTION, 2022, 117 (04) : 998 - 1008
  • [7] LONGITUDINAL RISK OF CIRRHOSIS ACROSS THE SPECTRUM OF STEATOTIC LIVER DISEASE AMONG A NATIONAL COHORT OF VETERANS IN THE UNITED STATES
    Wong, Robert
    Yang, Zeyuan
    Singal, Ashwani
    Pessoa, Mario
    Krag, Aleksander
    Schattenberg, Jorn
    Henry, Linda
    Alqahtani, Saleh
    Lazarus, Jeffrey
    Younossi, Zobair
    HEPATOLOGY, 2024, 80 : S825 - S826
  • [8] Evaluation of fidaxomicin usage patterns and outcomes for Clostridium difficile infection across the United States Veterans Health Administration
    Giancola, S. E.
    Williams, R. J., II
    Gentry, C. A.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2018, 43 (03) : 353 - 358
  • [9] Prevalence of the Clostridium difficile BI/NAP1/027 strain across the United States Veterans Health Administration
    Giancola, S. E.
    Williams, R. J., II
    Gentry, C. A.
    CLINICAL MICROBIOLOGY AND INFECTION, 2018, 24 (08) : 877 - 881
  • [10] Clinical decisions surrounding genomic and proteomic testing among United States veterans treated for lung cancer within the Veterans Health Administration
    Efimova, Olga
    Berse, Brygida
    Denhalter, Daniel W.
    DuVall, Scott L.
    Filipski, Kelly K.
    Icardi, Michael
    Kelley, Michael J.
    Lynch, Julie A.
    BMC MEDICAL INFORMATICS AND DECISION MAKING, 2017, 17